Supply Chain Disruptions And Their Impact On Quality And Operations

By Goff Baker

COVID-19’s impact on global supply chains as well as tectonic geopolitical shifts have resulted in considerable disruption, particularly to the contract development and manufacturing organization (CDMO) industry. Looking back, what is troubling about the supply chain challenges CDMOs faced during the past three years is that they were very similar to the issues plaguing many pharma manufacturers prior to the pandemic.

From the outside looking in, one might conclude: “the industry should have seen it coming.” However unfair the comment, it does serve to illuminate a critical point: Without fundamental supply chain transparency and communication, pharmaceutical manufacturers will never achieve the agility they need to deal with disruptions or emergencies of COVID-19 proportions.

In this blog, review pharma's global supply chain and the key principles that more effective high-performing supply chain operations and product quality are being built upon.